Hand-foot syndrome related to liposomal doxorubicin.
Swenson
Karen K
KK
Oncology Research Department, Park Nicollet Institute, Minneapolis, MN, USA. karen.swenson@parknicollet.com
Bell
Elaine M
EM
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced* / Q000451:nursing; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000451:nursing; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*
D000903:Antibiotics, Antineoplastic; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin